Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House approps

This article was originally published in The Tan Sheet

Executive Summary

Full committee approves FY 2002 budget language earmarking $307.5 mil. for CFSAN and its field offices, $349.4 mil. for CDER and its field offices. Report also calls for improvements in dietary supplement AE system, citing concern that FDA "has not taken proper steps to address the concerns outlined in the GAO and OIG reports" and directing agency "to follow the recommendations made by these reports." Recent HHS Office of Inspector General report found inadequacies in AER system and called for increased funding ("The Tan Sheet" April 23, pp. 3-6). Trade groups, congressmen recently have called for $3 mil. to improve system. Committee sets total FDA budget at $1.34 bil., roughly $700 mil. below Bush Administration proposal

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel